Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Talking generics in the UK with Mylan’s Jean-Yves Brault

Following the recent UK launch by Mylan of Brabio, the first generic version of Teva’s Copaxone for multiple sclerosis, we spoke to Mylan’s UK Country Manager Jean-Yves Brault about the drug, as well as the current opportunities and challenges in the UK’s generics market.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top